Wire to Wire Daily Stock Picking Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Wire to Wire Daily Stock Picking

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jeffrey L. Henken who wrote (942)	7/1/1999 9:33:00 AM
From: Henrik	Read Replies (1) of 3514

PGLAF - Henrik - 13.6M - 3 15/16 - Bid 3 3/8 - Ask 4 - FDA News Progen gets go-ahead for anti-cancer trial 10:25 Thursday, 1 July 1999 Sydney - Thursday - July 1: The United States Food and Drug Administration (FDA) has completed its review and given final clearance, June 30th, Washington time for Progen's PI-88 anti-cancer trial. With final FDA approval, Progen has now met all conditions for Royal Melbourne Hospital Ethics Committee approval and trials should commence in July/August.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next